Literature DB >> 33420288

In vitro antagonistic inhibitory effects of palm seed crude oils and their main constituent, lauric acid, with oxacillin in Staphylococcus aureus.

Klara Lalouckova1,2, Eva Skrivanova1,2, Johana Rondevaldova3, Adela Frankova4, Josef Soukup1, Ladislav Kokoska5.   

Abstract

Infections caused by Staphylococcus aureus are a serious global threat, and with the emergence of antibiotic resistance, even more difficult to treat. One of the possible complications in antistaphylococcal therapy represents negative interactions of antibiotics with food. In this study, the in vitro interaction between oxacillin and crude palm seed oil from Astrocaryum vulgare, Cocos nucifera, and Elaeis guineensis against nine strains of S. aureus was determined using the checkerboard method. Lauric acid was identified as a major constituent of all tested oils by gas chromatography. The results showed strong concentration dependent antagonistic interactions between palm oils and oxacillin with values of fractional inhibitory concentrations indices ranging from 4.02 to 8.56 at concentrations equal or higher than 1024 µg/mL of the tested oils. Similarly, lauric acid in combination with oxacillin produced antagonistic action with fractional inhibitory concentration indices ranging from 4.01 to 4.28 at 1024 µg/mL. These findings suggest that interference between oxacillin and palm oils and their constituents can negatively affect the treatment of staphylococcal infections in humans and other animals.

Entities:  

Year:  2021        PMID: 33420288      PMCID: PMC7794437          DOI: 10.1038/s41598-020-80481-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  74 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Food-drug interactions.

Authors:  Tsung O Cheng
Journal:  Int J Cardiol       Date:  2006-01-26       Impact factor: 4.164

3.  The well-being model: a new drug interaction model for positive and negative effects.

Authors:  Eleonora Zanderigo; Valentina Sartori; Gorazd Sveticic; Thomas Bouillon; Peter Schumacher; Manfred Morari; Michele Curatolo
Journal:  Anesthesiology       Date:  2006-04       Impact factor: 7.892

4.  [Antibiotics: drug and food interactions].

Authors:  M Hodel; D Genné
Journal:  Rev Med Suisse       Date:  2009-10-07

Review 5.  Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Authors:  David G Bailey; George Dresser; J Malcolm O Arnold
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

Review 6.  Alternative antimicrobials: the properties of fatty acids and monoglycerides.

Authors:  Colin P Churchward; Raid G Alany; Lori A S Snyder
Journal:  Crit Rev Microbiol       Date:  2018-05-07       Impact factor: 7.624

7.  Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.

Authors:  Teruaki Nakatsuji; Mandy C Kao; Jia-You Fang; Christos C Zouboulis; Liangfang Zhang; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

8.  Physical characterization and antioxidant activity of thymol solubilized Tween 80 micelles.

Authors:  Ling-Li Deng; Maierhaba Taxipalati; Fei Que; Hui Zhang
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

9.  Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women.

Authors:  Kay-Tee Khaw; Stephen J Sharp; Leila Finikarides; Islam Afzal; Marleen Lentjes; Robert Luben; Nita G Forouhi
Journal:  BMJ Open       Date:  2018-03-06       Impact factor: 2.692

10.  Corn Oil Lowers Plasma Cholesterol Compared with Coconut Oil in Adults with Above-Desirable Levels of Cholesterol in a Randomized Crossover Trial.

Authors:  Kevin C Maki; Wendy Hasse; Mary R Dicklin; Marjorie Bell; Mary A Buggia; Martha E Cassens; Fulya Eren
Journal:  J Nutr       Date:  2018-10-01       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.